Rod Raabe, M.D.
Founder and Chief Medical Officer
Dr. Raabe is an internationally renowned interventional radiologist and is the co-inventor of the Sapheon Closure System for the treatment of venous reflux disease. Dr. Raabe is the director of radiology at Sacred Heart Medical Center in Spokane, Washington. Dr. Raabe is a member of the Society of Interventional Radiology, the American Medical Association, the American College of Radiology, the American College of Phlebology, and the Radiological Society of North America. Dr. Raabe was also featured in a New York Times article and on ABC's Good Morning America®.
Monte A. Madsen, RDMS, RVT, RPhS
Monte Madsen was the Vascular Services Manager for Inland Imaging® Inc. for 23 years and has been involved in the forefront of venous diagnosis and treatment for over two decades. He is well respected in the area of vascular ultrasound and lectures regularly throughout the United States and Internationally. Monte has conducted training and education in venous disease diagnosis and treatment for over 10 years. Monte has authored a text reference on venous disease and treatment. Monte has one design patent pending. Monte attended the University of Wyoming; his specialty training was completed at University of Utah Medical Center.
Lawrence Rusty Hoffman, M.D.
Stanford University Medical Center, Associate Professor, Chief of Interventional Radiology. Dr. Hoffman is a member of the Society of Cardiovascular and Interventional Radiology and he is also a member of the American Roentgen Ray Society as well as numerous other medical affiliations.
James Quinn, M.D. M.S.
Associate Professor of Surgery and Director of Research in Emergency Medicine at Stanford University. Dr. Quinn is a world renowned expert on the medical uses of cyanoacrylates, having published 20 peer reviewed articles and a leading book on medical adhesives. Dr. Quinn is a medical consultant for Chemence® Inc., is a fellow of the American College of Emergency Physicians and is certified by the American Board of Emergency Medicine.
Robert Min, M.D.
New York-Presbyterian Hospital/Weill Cornell Medical Center, Chairman of Radiology at Weill Cornell Medical College and Radiologist-in-Chief at New York-Presbyterian Hospital. Dr. Min is the inventor of endovenous laser therapy for treating venous insufficiency and developed transcatheter duplex-guided sclerotherapy. Dr. Min is president and member of the Board of Directors of the American College of Phlebology, the largest medical society focused solely on venous conditions, with more than 2,000 members from 46 countries. He is also a founding member and serves as president-elect of the American Board of Phlebology. Dr. Min has authored or co-authored more than 50 scientific articles and abstracts on vascular conditions, and numerous book chapters on venous disorders.
Helen S. Barold, MD, MPH, FACC, FHRS
Medical Device Consultant, Bethesda MD. Dr. Barold has over 10 years of experience in Cardiology and Cardiac Electrophysiology. She has 8 years of experience in regulatory evaluation of medical devices. She was a medical officer in the Office of Device Evaluation at the FDA. She was the Chief Medical Officer for a medical device company that was recently acquired by a larger company. She has vast experience in FDA panel presentations both from the FDA side as well as the industry side.
Thomas M. Proebstle, M.D., PhD.
Faculty Member of the Universities of Mainz, Germany, and Pecs, Hungary; Professor of Dermatology (Cimzetes Egyetemi Docensse), University of Pecs, Hungary; Assistant Professor (Privatdozent), Department of Dermatology, University of Mainz, Germany. Dr. Proebstle is a leading interventional radiologist and the Director of Private Clinic Proebstle, Clinic for Dermatology, Phlebology and Aesthetic Medicine in Mannheim, Germany. His articles on treatment of saphenous vein disease have been published in numerous peer-reviewed journals in Europe and the United States.
Vascular Device Partners (VDP)
Independent Clinical Investigators